NO20062143L - Tablettformuleringer av venlafaxin med forlenget frigjoring - Google Patents

Tablettformuleringer av venlafaxin med forlenget frigjoring

Info

Publication number
NO20062143L
NO20062143L NO20062143A NO20062143A NO20062143L NO 20062143 L NO20062143 L NO 20062143L NO 20062143 A NO20062143 A NO 20062143A NO 20062143 A NO20062143 A NO 20062143A NO 20062143 L NO20062143 L NO 20062143L
Authority
NO
Norway
Prior art keywords
extended
tablet formulations
release venlafaxine
venlafaxine tablet
release
Prior art date
Application number
NO20062143A
Other languages
English (en)
Norwegian (no)
Inventor
Angela Potts
Michael Rowley
Edward Sims
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20062143L publication Critical patent/NO20062143L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20062143A 2003-10-13 2006-05-12 Tablettformuleringer av venlafaxin med forlenget frigjoring NO20062143L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03256439A EP1523981A1 (de) 2003-10-13 2003-10-13 Venlafaxine-Zubereitungen mit verlängerter Freisetzung
PCT/EP2004/011384 WO2005039555A1 (en) 2003-10-13 2004-10-12 Extended release tablet formulations of venlafaxine

Publications (1)

Publication Number Publication Date
NO20062143L true NO20062143L (no) 2006-07-07

Family

ID=34354597

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062143A NO20062143L (no) 2003-10-13 2006-05-12 Tablettformuleringer av venlafaxin med forlenget frigjoring

Country Status (15)

Country Link
US (1) US20050136109A1 (de)
EP (2) EP1523981A1 (de)
KR (1) KR20060118481A (de)
CN (1) CN1889939A (de)
AT (1) ATE409031T1 (de)
AU (1) AU2004283439A1 (de)
CA (1) CA2546203A1 (de)
CO (1) CO5690567A2 (de)
DE (1) DE602004016761D1 (de)
DK (1) DK1677776T3 (de)
EC (1) ECSP066564A (de)
ES (1) ES2313059T3 (de)
NO (1) NO20062143L (de)
WO (1) WO2005039555A1 (de)
ZA (1) ZA200603822B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1476139B1 (de) * 2002-02-21 2017-05-17 Valeant Pharmaceuticals Luxembourg S.à.r.l. Dosierformen mit kontrollierter freisetzung
US8323692B2 (en) 2002-02-21 2012-12-04 Valeant International Bermuda Controlled release dosage forms
CA2507685A1 (en) * 2002-11-28 2004-06-10 Themis Laboratories Private Limited Process for manufacturing sustained release microbeads containing venlafaxine hci
EP1473030B2 (de) † 2003-05-02 2014-05-14 Dexcel Ltd. Tablettenzubereitung mit verlängerter Freisetzung von Venlafaxin
WO2007129329A2 (en) * 2006-05-08 2007-11-15 Jubilant Organosys Limited Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
CN106176678A (zh) 2008-04-18 2016-12-07 因泰克制药有限公司 卡比多巴/左旋多巴胃滞留给药
EP2378883B1 (de) * 2008-12-04 2015-12-23 Intec Pharma Ltd. Magenretentives arzneistoffabgabesystem für zaleplon
EP2726066B1 (de) 2011-06-28 2021-03-31 Neos Therapeutics, LP Dosisformen für amphetamin zur oralen verabreichung
CN109771380A (zh) * 2017-11-10 2019-05-21 连云港恒运药业有限公司 去甲文拉法辛盐酸盐药物组合物及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
US5506270A (en) * 1995-01-30 1996-04-09 American Home Products Corporation Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women
US5554383A (en) * 1995-04-06 1996-09-10 Trustees Of Tufts College Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
DE10208335A1 (de) * 2002-02-27 2003-09-04 Roehm Gmbh Arzneiform und Verfahren zu ihrer Herstellung
AR039162A1 (es) * 2002-03-28 2005-02-09 Synthon Bv Formulaciones de venlafaxina de liberacion extendida
AU2003226751A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Low water-soluble venlafaxine salts
IL149055A0 (en) * 2002-04-09 2002-11-10 Karma Pharm Ltd Extended release composition comprising as active compound venlafaxine hydrochloride
BR0311693A (pt) * 2002-06-10 2005-03-22 Wyeth Corp Sal de formato de o-desmetil-venlafaxina

Also Published As

Publication number Publication date
AU2004283439A1 (en) 2005-05-06
CN1889939A (zh) 2007-01-03
US20050136109A1 (en) 2005-06-23
KR20060118481A (ko) 2006-11-23
CA2546203A1 (en) 2005-05-06
EP1677776B1 (de) 2008-09-24
DE602004016761D1 (de) 2008-11-06
DK1677776T3 (da) 2009-01-19
ATE409031T1 (de) 2008-10-15
ZA200603822B (en) 2008-05-28
WO2005039555A1 (en) 2005-05-06
EP1677776A1 (de) 2006-07-12
EP1523981A1 (de) 2005-04-20
ECSP066564A (es) 2006-10-17
CO5690567A2 (es) 2006-10-31
ES2313059T3 (es) 2009-03-01

Similar Documents

Publication Publication Date Title
UY30274A1 (es) Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones
CY1108823T1 (el) Παραγωγα 2-υδροξυ-3-ετεροαρυλινδολης ως αναστολεις της gsk3
BR0209431A (pt) Novos compostos de 4-anilinoquinolino-3-carboxamidas
IS8398A (is) Lyfjasamsetningar til að meðhöndla æxli
UY28671A1 (es) Pirido(2.3-d)pirimidina-2,4-diaminas como inhibidores de pde 2
DE60330909D1 (de) Tablette mit modifizierter freisetzung von bupropion hydrochlorid
ECSP088296A (es) Compuestos terapéuticos
UY30460A1 (es) Compuestos terapéuticos
CY1106929T1 (el) Κρυσταλλικες μορφες υδροχλωριδιου (-)-(1r,2r)-3-(3-διμεθυλαμινο-1-αιθυλο-2-μεθυλοπροπυλο)-φαινολης
CR9609A (es) Formulaciones de una sal de bupropion de liberacion modificada
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
NO20042807L (no) Farmasoytiske sammensetninger som innbefatter aktive vitamin D forbindelser
UY27226A1 (es) Pirazolopirimidinas como agentes terapéuticos
NO20043367L (no) Oralt farmasoytisk preparat
EA200970532A1 (ru) Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола
HN2002000198A (es) Composiciones farmaceuticas de amlodipina y atorvastatina
DE602005027540D1 (de) Feste formulierungen von ospemifen
MA31430B1 (fr) Formulation a liberation prolongee de nevirapine
NO20062143L (no) Tablettformuleringer av venlafaxin med forlenget frigjoring
BRPI0410044B8 (pt) forma de dosagem contendo pantoprazol como ingrediente ativo
CR7956A (es) Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos
ATE352305T1 (de) Stabile pharmazeutische zusammensetzungen mit desloratadine
ATE389405T1 (de) Fexofenadine hydrochlorid polymorph
NO331227B1 (no) Lineaere basiske forbindelser som har NK-2 antagonistaktivitet, farmasoytiske formuleringer derav og anvendelse av samme for fremstilling av farmasoytiske formuleringer
PA8545601A1 (es) Derivados de 4-aminopirimidina